Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Indian Pediatr ; 60(10): 834-838, 2023 10 15.
Artículo en Inglés | MEDLINE | ID: mdl-37480296

RESUMEN

OBJECTIVE: To determine the prevalence of impaired growth parameters (height and BMI z scores) among adolescents aged 10-19 years, with onset of idiopathic nephrotic syndrome between the age of 1 and 6 years. METHODS: A cross-sectional study was conducted among adolescents aged 10-19 years with onset of idiopathic nephrotic syndrome between the age of 1-6 years, and under regular follow-up at our center. The data were retrieved for a 10-year period (2012-2022). The current weight, height and body mass index (BMI) were recorded and interpreted as per world Health Organization (WHO) growth standards. RESULTS: 116 adolescents [60 Frequently relapsing nephrotic syndrome (FRNS)/Steroid dependent nephrotic syndrome (SDNS), and 56 Steroid resistant nephrotic syndrome (SRNS)] patients were enrolled with median (IQR) age of 133 (120,168) months and age at disease onset of 48 (26,68) months. The proportion of children with overweight (BMI for age >1z and cushingoid features), obesity (BMI for age >2z), stunting (height for age (HFA) <2z), and severe stunting (HFA <3z) were 29 (25%), 3 (2.6%), 31 (26.7%), and 7 (6%), respectively. The median (IQR) cumulative steroid dose for FRNS/SDNS and SRNS group was 19986.96 (14597.1, 26181.96) mg/m2 and 14385 (10758.82, 21355.95) mg/m2, respectively (P=0.003). CONCLUSION: The proportion of short stature and overweight was high among adolescents with nephrotic syndrome, emphasizing the need for measures to reduce steroid use and other measures to support growth.


Asunto(s)
Glucocorticoides , Trastornos del Crecimiento , Síndrome Nefrótico , Sobrepeso , Adolescente , Niño , Preescolar , Humanos , Lactante , Estudios Transversales , Trastornos del Crecimiento/inducido químicamente , Trastornos del Crecimiento/diagnóstico , Trastornos del Crecimiento/etiología , Inmunosupresores/efectos adversos , Inmunosupresores/uso terapéutico , Síndrome Nefrótico/complicaciones , Síndrome Nefrótico/tratamiento farmacológico , Sobrepeso/inducido químicamente , Sobrepeso/diagnóstico , Sobrepeso/etiología , Recurrencia , Adulto Joven , Prevalencia , Glucocorticoides/efectos adversos , Glucocorticoides/uso terapéutico , Pesos y Medidas Corporales
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA